In contrast, a single study of 3285 patients referred to an osteoporosis clinic, reported a higher prevalence of patients with an ALPL variant (14 out of 16 patients with hypophosphatasaemia) including four subjects treated with BPs (Alonso et al., 2020). This evidence concerns the gene ALPL and osteoporosis.